Strs Ohio Arcus Biosciences, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, Strs Ohio holds 8,500 shares of RCUS stock, worth $133,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,500

Previous 6,900 23.19%

Holding current value

$133,450

Previous $105,000 22.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$13.69 - $18.01 $21,904 - $28,816	1,600 Added 23.19%	8,500 $129,000
Q2 2024 Aug 05, 2024	BUY	$14.59 - $18.48 $100,671 - $127,512	6,900 New	6,900 $105,000
Q4 2023 Jan 30, 2024	BUY	$13.43 - $19.63 $79,237 - $115,817	5,900 Added 245.83%	8,300 $158,000
Q3 2023 Oct 26, 2023	BUY	$17.62 - $23.54 $42,288 - $56,496	2,400 New	2,400 $43,000
Q1 2023 Aug 02, 2023	BUY	$15.96 - $23.15 $360,696 - $523,189	22,600 New	22,600 $412,000
Q1 2023 Apr 27, 2023	SELL	$15.96 - $23.15 $55,860 - $81,025	-3,500 Reduced 13.41%	22,600 $412,000
Q4 2022 Jan 26, 2023	SELL	$19.7 - $35.71 $128,050 - $232,115	-6,500 Reduced 19.94%	26,100 $539,000
Q3 2022 Oct 27, 2022	SELL	$23.23 - $30.07 $39,491 - $51,119	-1,700 Reduced 4.96%	32,600 $852,000
Q2 2022 Jul 25, 2022	BUY	$17.23 - $37.73 $590,989 - $1.29 Million	34,300 New	34,300 $869,000
Q4 2021 Jan 24, 2022	SELL	$31.38 - $48.47 $514,632 - $794,908	-16,400 Closed	0 $0
Q2 2021 Jul 26, 2021	BUY	$22.75 - $35.77 $102,375 - $160,965	4,500 Added 37.82%	16,400 $450,000
Q1 2021 Apr 23, 2021	SELL	$26.16 - $41.39 $180,504 - $285,591	-6,900 Reduced 36.7%	11,900 $334,000
Q4 2020 Jan 25, 2021	BUY	$17.0 - $32.36 $102,000 - $194,160	6,000 Added 46.88%	18,800 $488,000
Q3 2020 Dec 14, 2020	SELL	$17.14 - $25.47 $8,570 - $12,735	-500 Reduced 3.76%	12,800 $219,000
Q2 2020 Jul 23, 2020	BUY	$13.97 - $36.56 $185,801 - $486,248	13,300 New	13,300 $329,000
Q4 2018 Jan 23, 2019	SELL	$9.74 - $14.5 $0 - $0	0 Closed	0 $0
Q3 2018 Oct 19, 2018	SELL	$10.88 - $14.95 $16,320 - $22,425	-1,500 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$12.24 - $17.05 $18,360 - $25,575	1,500 New	1,500 $18,000

Others Institutions Holding RCUS

# of Institutions

201

Shares Held

51.7M

Call Options Held

236K

Put Options Held

141K

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $1.13B
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account